ATRA
ATRA
NASDAQ · Biotechnology

Atara Biotherapeutics Inc

$4.88
+0.37 (+8.20%)
As of Feb 8, 2:21 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 4.92M 4.60M 4.74M
Net Income -168,115 -132,709 -155,737
EPS
Profit Margin -3.4% -2.9% -3.3%
Rev Growth -1.4% -8.7% +11.4%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 17.50M 15.40M 16.39M
Total Equity 19.37M 18.11M 18.20M
D/E Ratio 0.90 0.85 0.90
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -202,888 -214,542 -195,381
Free Cash Flow -99,394 -85,981 -141,773